Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967157 · ClinicalTrials.gov registry record · NA
Cognitive Effects of Citicoline on Attention in Healthy Mean and Women
A NA study, sponsored by Kirin Holdings Company, Limited.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT04967157: Completed NA study, sponsored by Kirin Holdings Company, Limited.
NCT04967157 is a NA study that has completed, run by Kirin Holdings Company, Limited. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04967157, a NA study, has completed, sponsored by Kirin Holdings Company, Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The objective of this trial is to determine the effects of citicoline on cognitive performance for attention in healrhy Men and Women compared to a placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo supplement
- DIETARY_SUPPLEMENT Citicoline supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04967157
The ClinicalTrials.gov registry entry for NCT04967157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kirin Holdings Company, Limited, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo supplement is the first listed.
NCT04967157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04967157 about?
NCT04967157 is a clinical study titled "Cognitive Effects of Citicoline on Attention in Healthy Mean and Women". The objective of this trial is to determine the effects of citicoline on cognitive performance for attention in healrhy Men and Women compared to a placebo.
What is the current status of trial NCT04967157?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2021-09-08. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04967157?
The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Citicoline supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04967157?
This trial is sponsored by Kirin Holdings Company, Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.